Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milo Gatti

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
Antibiotics (Basel, Switzerland)|May 24, 2024
Efficacy of a Novel Prophylactic Scheme of Fosfomycin Trometamol in Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia: Findings from a Prospective Monocentric Single-Arm StudyPasquale Maria Berrino, Milo Gatti, Valeria Rotaru, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2023
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysisMilo Gatti, Cecilia Bonazzetti, Beatrice Tazza, et al.
Frontiers in Pharmacology|October 14, 2021
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric SettingsMilo Gatti, Pier Giorgio Cojutti, Caterina Campoli, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2025
TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipientGiovanni Mulé, Giulia Coniglione, Milo Gatti, et al.
Mycoses|August 13, 2021
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysisMilo Gatti, Matteo Rinaldi, Giuseppe Ferraro, et al.
International Journal of Antimicrobial Agents|April 19, 2026
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?Milo Gatti, Cecilia Bonazzetti, Benedetta Secci, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 17, 2021
Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patientPaolo Gaibani, Milo Gatti, Matteo Rinaldi, et al.
The Journal of Infectious Diseases|January 24, 2025
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, studyMilo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2025
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing <i>Klebsiella pneumoniae</i> infections and on ceftazidime/avibactam resistance developmentMilo Gatti, Matteo Rinaldi, Pier Giorgio Cojutti, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> InfectionsGiuseppe Pipitone, Stefano Di Bella, Alberto Enrico Maraolo, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Antibiotics (Basel, Switzerland)|May 24, 2024
Efficacy of a Novel Prophylactic Scheme of Fosfomycin Trometamol in Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia: Findings from a Prospective Monocentric Single-Arm StudyPasquale Maria Berrino, Milo Gatti, Valeria Rotaru, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2023
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysisMilo Gatti, Cecilia Bonazzetti, Beatrice Tazza, et al.
Frontiers in Pharmacology|October 14, 2021
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric SettingsMilo Gatti, Pier Giorgio Cojutti, Caterina Campoli, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2025
TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipientGiovanni Mulé, Giulia Coniglione, Milo Gatti, et al.
Mycoses|August 13, 2021
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysisMilo Gatti, Matteo Rinaldi, Giuseppe Ferraro, et al.
International Journal of Antimicrobial Agents|April 19, 2026
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?Milo Gatti, Cecilia Bonazzetti, Benedetta Secci, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 17, 2021
Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patientPaolo Gaibani, Milo Gatti, Matteo Rinaldi, et al.
The Journal of Infectious Diseases|January 24, 2025
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, studyMilo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2025
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing <i>Klebsiella pneumoniae</i> infections and on ceftazidime/avibactam resistance developmentMilo Gatti, Matteo Rinaldi, Pier Giorgio Cojutti, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> InfectionsGiuseppe Pipitone, Stefano Di Bella, Alberto Enrico Maraolo, et al.
Pageof 17